Cargando…
On a mission to block transmission
The controlled infection of volunteers with Plasmodium falciparum parasites could provide a platform to evaluate new drugs and vaccines aimed at blocking malaria transmission.
Autores principales: | Ross, Amanda, Brancucci, Nicolas MB |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
eLife Sciences Publications, Ltd
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5828661/ https://www.ncbi.nlm.nih.gov/pubmed/29485403 http://dx.doi.org/10.7554/eLife.35246 |
Ejemplares similares
-
Genetic validation of PfFKBP35 as an antimalarial drug target
por: Thommen, Basil T, et al.
Publicado: (2023) -
COVID-19: A Retrospective Cohort Study of Nosocomial Transmission in a District General Hospital
por: Duffaydar, Hamza, et al.
Publicado: (2022) -
Sensitizing Staphylococcus aureus to antibacterial agents by decoding and blocking the lipid flippase MprF
por: Slavetinsky, Christoph J, et al.
Publicado: (2022) -
Sexual transmission of murine papillomavirus (MmuPV1) in Mus musculus
por: Spurgeon, Megan E, et al.
Publicado: (2019) -
Structural basis of malaria transmission blockade by a monoclonal antibody to gamete fusogen HAP2
por: Feng, Juan, et al.
Publicado: (2021)